These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1971905)
1. HTLV-I/II antibodies in French blood donors. Coste J; Lemaire JM; Barin F; Courouce AM Lancet; 1990 May; 335(8698):1167-8. PubMed ID: 1971905 [No Abstract] [Full Text] [Related]
2. Absence of antibodies to HTLV-I/II in French patients with hematological malignancies. Agius G; Vaillant V; Biggar RJ; Brizard A; Ranger S; Dindinaud G; Castets M Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):815-6. PubMed ID: 3145872 [No Abstract] [Full Text] [Related]
3. Very low seroprevalence of HTLV-I/II in Cuba: antibodies in blood donors and in hematological and nonhematological patients. Hernandez Ramirez P; Rivero Jimenez R; Ballester Santovenia M; Navea Leyva L; Matutes E; Catovsky D; Yamaguchi K; Fukuyoshi Y; Nishimura Y; Kiyokawa T Vox Sang; 1991; 61(4):277-8. PubMed ID: 1685604 [No Abstract] [Full Text] [Related]
4. [Epidemiologic study of anti-HTLV-I/II antibodies in blood donors in metropolitan France. The Retrovirus Working Group of the National Blood Transfusion Society]. Lemaire JM; Coste J; Barin F; Couroucé AM Rev Fr Transfus Hemobiol; 1991 Jan; 34(1):21-34. PubMed ID: 2015034 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054 [TBL] [Abstract][Full Text] [Related]
6. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant? Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of HTLV-I and HTLV-II. Zanetti AR; Galli C N Engl J Med; 1992 Jun; 326(26):1783; author reply 1783-4. PubMed ID: 1350659 [No Abstract] [Full Text] [Related]
9. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires. Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia. Ul-Hassan Z; Al-Bahrani AT; Panhotra BR Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814 [TBL] [Abstract][Full Text] [Related]
11. Absence of markers for HTLV infection among australian injecting drug users. Crofts N; Silvester C; Ross M Med J Aust; 1992 Jul; 157(1):70-1. PubMed ID: 1353605 [No Abstract] [Full Text] [Related]
12. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal. Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891 [TBL] [Abstract][Full Text] [Related]
13. Demonstration of HTLV-related proviral DNA sequences and antibodies reactive with HTLV internal proteins in an Hungarian patient with Sézary syndrome. Kiss J; Kiss A; Tóth FD; Surányi P; Szegedi A; Rak K Leuk Lymphoma; 1992 Aug; 7(5-6):511-5. PubMed ID: 1362917 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico. Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II. Kline RL; Brothers T; Halsey N; Boulos R; Lairmore MD; Quinn TC Lancet; 1991 Jan; 337(8732):30-3. PubMed ID: 1670658 [TBL] [Abstract][Full Text] [Related]
16. Antigenic variations of retrovirus in Japanese cancer patients. Maruyama K; Miyauchi M; Fukushima T; Mochizuki S; Koshikawa N; Kawamura K; Tamayama C; Nakano M; Odo A; Iha S Leukemia; 1989 Apr; 3(4):277-81. PubMed ID: 2927177 [TBL] [Abstract][Full Text] [Related]
17. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805 [TBL] [Abstract][Full Text] [Related]
18. HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection. Varnier OE; Lillo F; Alexander SS; Forbis RM; Present W; Lazzarin A JAMA; 1991 Feb; 265(5):597. PubMed ID: 1987408 [No Abstract] [Full Text] [Related]
19. Hepatitis B and C viruses, human T-cell lymphotropic virus types I and II, and leukemias: a case-control study. The Italian Leukemia Study Group. Gentile G; Mele A; Monarco B; Vitale A; Pulsoni A; Visani G; Castelli G; Rapicetta M; Verani P; Martino P; Mandelli F Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):227-30. PubMed ID: 8833624 [TBL] [Abstract][Full Text] [Related]
20. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia. Fawaz NA; Tamim H; Almawi WY Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]